A Thermostable mRNA Vaccine against COVID-19

被引:496
|
作者
Zhang, Na-Na [1 ,2 ]
Li, Xiao-Feng [1 ]
Deng, Yong-Qiang [1 ]
Zhao, Hui [1 ]
Huang, Yi-Jiao [1 ]
Yang, Guan [3 ]
Huang, Wei-Jin [4 ]
Gao, Peng [5 ]
Zhou, Chao [1 ]
Zhang, Rong-Rong [1 ]
Guo, Yan [1 ]
Sun, Shi-Hui [1 ]
Fan, Hang [1 ]
Zu, Shu-Long [1 ]
Chen, Qi [1 ]
He, Qi [3 ]
Cao, Tian-Shu [1 ]
Huang, Xing-Yao [1 ]
Qiu, Hong-Ying [1 ]
Nie, Jian-Hui [4 ]
Jiang, Yuhang [5 ]
Yan, Hua-Yuan [5 ]
Ye, Qing [1 ]
Zhong, Xia [5 ]
Xue, Xia-Lin [5 ]
Zha, Zhen-Yu [5 ]
Zhou, Dongsheng [1 ]
Yang, Xiao [3 ]
Wang, You-Chun [4 ]
Ying, Bo [5 ]
Qin, Cheng-Feng [1 ]
机构
[1] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China
[2] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
[3] Beijing Inst Life, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China
[4] Natl Inst Food & Drug Control NIFDC, Inst Biol Prod Control, Div HIV AIDS & Sex Transmitted Virus Vaccines, Beijing 102629, Peoples R China
[5] Suzhou Abogen Biosci Co Ltd, Suzhou 215123, Peoples R China
关键词
INFECTION;
D O I
10.1016/j.cell.2020.07.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is an urgent need for vaccines against coronavirus disease 2019 (COVID-19) because of the ongoing SARS-CoV-2 pandemic. Among all approaches, a messenger RNA (mRNA)-based vaccine has emerged as a rapid and versatile platform to quickly respond to this challenge. Here, we developed a lipid nanoparticle-encapsulated mRNA (mRNA-LNP) encoding the receptor binding domain (RBD) of SARS-CoV-2 as a vaccine candidate (called ARCoV). Intramuscular immunization of ARCoV mRNA-LNP elicited robust neutralizing antibodies against SARS-CoV-2 as well as a Th1-biased cellular response in mice and non-human primates. Two doses of ARCoV immunization in mice conferred complete protection against the challenge of a SARS-CoV-2 mouse-adapted strain. Additionally, ARCoV is manufactured as a liquid formulation and can be stored at room temperature for at least 1 week. ARCoV is currently being evaluated in phase 1 clinical trials.
引用
收藏
页码:1271 / +
页数:29
相关论文
共 50 条
  • [1] A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines
    Aurélien vander Straeten
    Morteza Sarmadi
    John L. Daristotle
    Maria Kanelli
    Lisa H. Tostanoski
    Joe Collins
    Apurva Pardeshi
    Jooli Han
    Dhruv Varshney
    Behnaz Eshaghi
    Johnny Garcia
    Timothy A. Forster
    Gary Li
    Nandita Menon
    Sydney L. Pyon
    Linzixuan Zhang
    Catherine Jacob-Dolan
    Olivia C. Powers
    Kevin Hall
    Shahad K. Alsaiari
    Morris Wolf
    Mark W. Tibbitt
    Robert Farra
    Dan H. Barouch
    Robert Langer
    Ana Jaklenec
    [J]. Nature Biotechnology, 2024, 42 : 510 - 517
  • [2] A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines
    vander Straeten, Aurelien
    Sarmadi, Morteza
    Daristotle, John L.
    Kanelli, Maria
    Tostanoski, Lisa H.
    Collins, Joe
    Pardeshi, Apurva
    Han, Jooli
    Varshney, Dhruv
    Eshaghi, Behnaz
    Garcia, Johnny
    Forster, Timothy A.
    Li, Gary
    Menon, Nandita
    Pyon, Sydney L.
    Zhang, Linzixuan
    Jacob-Dolan, Catherine
    Powers, Olivia C.
    Hall, Kevin
    Alsaiari, Shahad K.
    Wolf, Morris
    Tibbitt, Mark W.
    Farra, Robert
    Barouch, Dan H.
    Langer, Robert
    Jaklenec, Ana
    [J]. NATURE BIOTECHNOLOGY, 2024, 42 (03) : 510 - 517
  • [3] Receipt of mRNA Vaccine against Covid-19 and Myocarditis
    Caforio, Alida L. P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (23): : 2189 - 2190
  • [4] Shingles and mRNA COVID-19 vaccine
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    [J]. CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2021, 10 (03) : 292 - 292
  • [5] Morphea and COVID-19 mRNA vaccine
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (05) : E162 - E162
  • [6] COVID-19 mRNA vaccine allergy
    Risma, Kimberly A.
    [J]. CURRENT OPINION IN PEDIATRICS, 2021, 33 (06) : 610 - 617
  • [7] COVID-19 mRNA Vaccine Effectiveness against Elderly Frail People
    Kountouras, Jannis
    Tzitiridou-Chatzopoulou, Maria
    Papaefthymiou, Apostolis
    Chatzopoulos, Dimitrios
    Doulberis, Michael
    [J]. MEDICINA-LITHUANIA, 2023, 59 (02):
  • [8] Acute myocarditis after mRNA vaccine against COVID-19: A Correspondence
    Gomes, Daniel A.
    Santos, Rita R.
    Freitas, Pedro
    Paiva, Mariana S.
    Ferreira, Jorge
    Trabulo, Marisa
    [J]. ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2022, 119 (06) : 1006 - 1007
  • [9] A decavalent composite mRNA vaccine against both influenza and COVID-19
    Wang, Yang
    Ma, Qinhai
    Li, Man
    Mai, Qianyi
    Ma, Lin
    Zhang, Hong
    Zhong, Huiling
    Mai, Kailin
    Cheng, Nan
    Feng, Pei
    Guan, Peikun
    Wu, Shengzhen
    Zhang, Lu
    Dai, Jun
    Zhang, Biliang
    Pan, Weiqi
    Yang, Zifeng
    [J]. MBIO, 2024, 15 (09):
  • [10] Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
    Regev-Yochay, Gili
    Gonen, Tal
    Gilboa, Mayan
    Mandelboim, Michal
    Indenbaum, Victoria
    Amit, Sharon
    Meltzer, Lilac
    Asraf, Keren
    Cohen, Carmit
    Fluss, Ronen
    Biber, Asaf
    Nemet, Ital
    Kliker, Limor
    Joseph, Gili
    Doolman, Ram
    Mendelson, Ella
    Freedman, Laurence S.
    Harats, Dror
    Kreiss, Yitshak
    Lustig, Yaniv
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (14): : 1377 - 1380